Abstract
Since HIV infection could condition the natural history of parenterally transmitted viral hepatitis (HBV, HCV, HDV), with possibly differing effects in different risk groups, we decided to retrospectively examine sera from a cohort of 637 HIV seropositive patients in different stages of infection, seen from 1985 to 1992, to study the prevalence and temporal course of these infections. Virological markers of HBV, HCV and HDV were determined by ELISA and RIBA methods. The severity of HIV infection was higher in homosexuals than in drug addicts. Prevalence of antiHBc antibodies was 82% in drug addicts and 77% in homosexuals, whereas antiHCV antibodies prevalence was 72% in drug addicts and only 7% in homosexuals (p<0.000001). When only antiHBc-positive patients were considered, there was a significant difference in antiHBs antibodies between drug addicts (DA) and homosexuals (OR for DA 0.29, 95% CI 0.08/0.83,p=0.02), suggesting that drug addicts are less able to produce a protective response. This fact cannot be explained by the severity of HIV infection (which was higher among the homosexual group) and suggests some immunodepressive effect of drug abuse. Delta infection was only detected in the drug addict group, and the prevalence was low. Finally, we cannot confirm the interference of HCV infection with the speed of HBsAg clearance: in this study the prevalence of HBsAg was almost the same in HCV-positive and negative patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bresters D, Mauser-Bunschoten EP, Reesink HW, et al. Sexual transmission of hepatitis C virus. Lancet 1993; 342: 210–211.
Brown SM, Stimmel B, Taub RN, Kochwa S, Rosenfield RE. Immunologic dysfunction in heroin addicts. Arch Intern Med 1974; 134: 1001–1006.
Caredda F, d'Arminio Monforte A, Rossi E, Farci P, Smedile A, Tappero G, Moroni M. Prospective study of epidemic Delta infection in drug addicts. Viral hepatitis and Delta infection. New York: Alan R. Liss, Inc, 1983; 245–250
Chamot E, Hirschel B, Wintsch J, et al. Loss of antibodies against hepatitis C virus in HIV — seropositive intravenous drug users. AIDS 1990; 4: 1275–1277.
Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus among risk groups in Spain. Lancet 1989; ii: 294–297.
Francisci D, Ciriello S, Antonelli S, et al. L'epatite acuta virale: modificazioni osservate in Umbria. Atti della Acc. Anatomico — Chirugica di Perugia 1989; 80: 85–93.
Hallam NF, Fletcher ML, Read SJ, Majid AM, Kurtz JB, Rizza CR. Low risk of sexual transmission of Hepatitis C virus. J Med Virol 1993; 40; 251–253.
Hayashi PH, Flynn N, McCurdy SA, Kuramoto IK, Holland PV, Zelddis JB. Prevalence of Hepatitis C virus antibodies among patients infected with Human Immunodeficiency Virus J Med Vir 1991; 33: 177–180.
Huemer HP, Prodinger WM, Larcher C, Most J, Dierich MP. Correlation of hepatitis C virus antibodies with HIV-1 seropositivity in intravenous drug addicts. Infection 1990; 18: 122–123.
I-Shyan Sheen, Yun-Fan Liaw, Chia-Ming Chu, Chia-C Pao. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. The Journal of Infectious Diseases 1992; 165: 831–834.
Krogsgaard K, Liolhart BO, Nielsen JO, Andersson P, Kryger P, Aldershville J, Gerstoft J, Pederson C. The influence of HTLV III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology 1987; 7: 37–41.
Laskus T, Radkowski M, Lupa E, Slusarczyk J, Cianciara J, Halama G, Nowicka R. Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland. J Hepatology 1992; 15: 114–117.
Marcellin P, Martinot-Peignoux M, Boyer N et al. Second generation (RIBA) test in diagnosis of chronic hepatitis C. Lancet 1991; 337: 551–552.
McDonald JA, Harris S, Waters JA, Thomas HC. Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B hepatic viral antigens display. Journal of Hepatology 1987; 4: 337–342.
Melbye M, Biggar RJ, Wantzin P. Sexual trasmission of hepatitis C virus: cohort study (1981–89) among European homosexual men. British Medical Journal 1990; 301: 210–212.
Monno L, Angarano G, Lo Caputo S, Casalino G, Carbonara S, Santantonio T, Pollice L, Pastore G. Unfavourable outcome of acute hepatitis B in anti-HIV-positive drug addicts. In: Zuckerman AJ (ed), Viral Hepatitis and Liver Disease. New York: Alan R. Liss, Inc, 1988; 205–206.
Osmond DH, Charlebois E, Sheppard HW, Page K, Winkelstein W, Moss AR, Pengold A. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993; 167: 65–71.
Purcell RH, Gerin JL. Epidemiology of the Delta agent: an introduction. Viral Hepatitis and Delta infection. New York: Alan R. Liss, Inc, 1983; 113–119.
Rabin BS, D'Amada C. Immunoglobulin alterations associated with heroin addiction. Clin Exp Immunol 1973; 14: 359–363.
Redfield RR, Wright DG, Tramont EC. The Walter Reed staging classification for HTLV III/ LAV infection. The New England Journal of Medicine 1986; 314; 2: 131–132.
Sirchia G, Bellobuono A, Giovannetti A, Marconi M. Antibodies to hepatitis C virus in Italian blood donors. Lancet 1989; Sept 30: 797.
Van den Hoek JAR, Van Haastrecht HJA, Goudsmit J, De Wolf F, Coutinho RA. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. The Journal of Infectious Diseases 1990; 162: 823–826.
Zeldis JB, Sunita J, Kuramoto IK, Richards C, Sazama K, Samuels S, Holland PV, Flynn N. Seroepidemiology of viral infections among intravenous drug users in northern California. The Western Journal of Medicine 1992; 156: 30–35.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Francisci, D., Baldelli, F., Papili, R. et al. Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients. Eur J Epidemiol 11, 123–126 (1995). https://doi.org/10.1007/BF01719475
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01719475